FDA Approved: CAREONE IBUPROFEN — Supplemental Application (American Sales Company)

View source ↗

Summary

The FDA approved a supplemental application for CAREONE IBUPROFEN (ibuprofen) filed by American Sales Company under ANDA077349.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• CAREONE IBUPROFEN (IBUPROFEN)

Snippet

SUPPL AP for CAREONE IBUPROFEN (IBUPROFEN)